Literature DB >> 2109147

The control of 5-hydroxytryptamine and dopamine synthesis in the brain: a theoretical approach.

F A Hommes1, J S Lee.   

Abstract

The transport of the eight amino acids (phenylalanine, tyrosine, tryptophan, valine, leucine, isoleucine, histidine and methionine) using the large neutral amino acid transporter of the blood-brain barrier (BBB) has been calculated using published kinetic data. The fate of the amino acids has been followed from blood to interstitial space, to cell and through metabolism which included, for tyrosine and tryptophan, the hydroxylases. The system was analysed in terms of flux control coefficients. Since the summation theorem did not hold, the system clearly behaved as a non-homogeneous system. At physiological levels of these eight amino acids, the largest contribution to the control of the flux of tyrosine is given by the hydroxylase step, followed by the diffusional component of the transport across the BBB. For tryptophan it is the hydroxylase step, followed by the carrier-mediated transport across the BBB. For the other amino acids it is the metabolism, followed by the diffusional component of the BBB transport. These parameters for tyrosine and tryptophan were determined at increased levels of blood phenylalanine, tyrosine or histidine. The flux through tryptophan hydroxylase can be affected by high blood levels of tyrosine and histidine to values also observed in hyperphenylalaninaemia. Since hypertyrosinaemia (type II) and hyperhistidinaemia are not associated with mental retardation, it is concluded that interference with transport across the BBB of tyrosine and tryptophan, as well as the flux through tryptophan hydroxylase leading to the synthesis of 5-hydroxytryptamine, do not contribute to the cause of permanent brain dysfunction in hyperphenylalaninaemia. It can be calculated that addition of tyrosine to the diet to raise the blood tyrosine level in phenylketonuria patients may have a beneficial effect for the synthesis of neurotransmitters derived from tyrosine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109147     DOI: 10.1007/bf01799331

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  32 in total

1.  Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain.

Authors:  A V Mackay; P Davies; A J Dewar; C M Yates
Journal:  J Neurochem       Date:  1978-04       Impact factor: 5.372

2.  Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria.

Authors:  H C Lou; C Lykkelund; A M Gerdes; H Udesen; P Bruhn
Journal:  Acta Paediatr Scand       Date:  1987-07

3.  Kinetics of tryptophan transport across the blood-brain barrier.

Authors:  O E Pratt
Journal:  J Neural Transm Suppl       Date:  1979

4.  Inhibitors of purified beef adrenal tyrosine hydroxylase.

Authors:  S Udenfriend; P Zaltzman-Nirenberg; T Nagatsu
Journal:  Biochem Pharmacol       Date:  1965-05       Impact factor: 5.858

5.  Metabolic control and its analysis. Extensions to the theory and matrix method.

Authors:  H M Sauro; J R Small; D A Fell
Journal:  Eur J Biochem       Date:  1987-05-15

6.  Metabolic control analysis of moiety-conserved cycles.

Authors:  J H Hofmeyr; H Kacser; K J van der Merwe
Journal:  Eur J Biochem       Date:  1986-03-17

7.  Large doses of tryptophan and tyrosine as potential therapeutic alternative to dietary phenylalanine restriction in phenylketonuria.

Authors:  H Lou
Journal:  Lancet       Date:  1985-07-20       Impact factor: 79.321

Review 8.  Brain metabolism: a perspective from the blood-brain barrier.

Authors:  W M Pardridge
Journal:  Physiol Rev       Date:  1983-10       Impact factor: 37.312

9.  Follow-up study of a nation-wide neonatal metabolic screening program in Japan. A collaborative study group of neonatal screening for inborn errors of metabolism in Japan.

Authors:  K Tada; H Tateda; S Arashima; K Sakai; T Kitagawa; K Aoki; S Suwa; M Kawamura; T Oura; M Takesada
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

10.  Phenylalanine alters the mean power frequency of electroencephalograms and plasma L-dopa in treated patients with phenylketonuria.

Authors:  W Krause; C Epstein; A Averbook; P Dembure; L Elsas
Journal:  Pediatr Res       Date:  1986-11       Impact factor: 3.756

View more
  4 in total

1.  Modelling amino acid metabolism.

Authors:  M Hjelm; J Seakins
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

2.  Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria.

Authors:  G M Knudsen; S Hasselbalch; P B Toft; E Christensen; O B Paulson; H Lou
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  The effect of plasma valine, isoleucine and leucine on the control of the flux through tyrosine- and tryptophan-hydroxylase in the brain.

Authors:  F A Hommes; J S Lee
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

4.  Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice.

Authors:  Danique van Vliet; Vibeke M Bruinenberg; Priscila N Mazzola; Martijn H J R van Faassen; Pim de Blaauw; Ido P Kema; M Rebecca Heiner-Fokkema; Rogier D van Anholt; Eddy A van der Zee; Francjan J van Spronsen
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.